Mednet Logo
HomeQuestion

How would you approach therapy for relapsed/refractory mantle cell lymphoma restricted to the CNS?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · Rutgers Cancer Institute of New Jersey

CNS involvement by mantle cell lymphoma is an uncommon and high-risk scenario. Although it can be seen at diagnosis, it is more common at relapse, particularly CNS-only disease.

Optimal treatment depends on multiple factors, including prior treatment and response, age, performance status, underlyin...

Register or Sign In to see full answer

How would you approach therapy for relapsed/refractory mantle cell lymphoma restricted to the CNS? | Mednet